Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure

被引:152
作者
Felker, GM
Gattis, WA
Leimberger, JD
Adams, KF
Cuffe, MS
Gheorghiade, M
O'Connor, CM
机构
[1] Duke Clin Res Inst, Durham, NC 27715 USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Northwestern Univ, Chicago, IL 60611 USA
关键词
D O I
10.1016/S0002-9149(03)00740-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the prevalence of anemia and its relation to clinical events in patients with decompensated heart failure enrolled in the OPTIME-CHF study. Our data demonstrate that anemia is common in patients hospitalized with decompensated heart failure and is associated with a greater number of co-morbid conditions. Lower baseline hemoglobin is associated with risk of short-term adverse clinical outcomes in this population, even after controlling for other baseline differences. (C) 2003 by Excerpta Medica, Inc.
引用
收藏
页码:625 / 628
页数:4
相关论文
共 9 条
[1]   Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].
Al-Ahmad, A ;
Rand, WM ;
Manjunath, G ;
Konstam, MA ;
Salem, DN ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962
[2]   Hemodilution is common in patients with advanced heart failure [J].
Androne, AS ;
Katz, SD ;
Lund, L ;
LaManca, J ;
Hudaihed, A ;
Hryniewicz, K ;
Mancini, DM .
CIRCULATION, 2003, 107 (02) :226-229
[3]   Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial [J].
Cuffe, MS ;
Califf, RM ;
Adams, KF ;
Benza, R ;
Bourge, R ;
Colucci, WS ;
Massie, BM ;
O'Connor, CM ;
Pina, I ;
Quigg, R ;
Silver, MA ;
Georghiade, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (12) :1541-1547
[4]   Rationale and design of the OPTIME CHF trial: Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure [J].
Cuffe, MS ;
Califf, RM ;
Adams, KF ;
Bourge, RC ;
Colucci, W ;
Massie, B ;
O'Connor, CM ;
Pina, I ;
Quigg, R ;
Silver, M ;
Robinson, LA ;
Leimberger, JD ;
Gheorghiade, M .
AMERICAN HEART JOURNAL, 2000, 139 (01) :15-22
[5]   Anemia is common in heart failure and is associated with poor outcomes - Insights from a cohort of 12,065 patients with new-onset heart failure [J].
Ezekowitz, JA ;
McAlister, FA ;
Armstrong, PW .
CIRCULATION, 2003, 107 (02) :223-225
[6]   Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure [J].
Horwich, TB ;
Fonarow, GC ;
Hamilton, MA ;
MacLellan, WR ;
Borenstein, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1780-1786
[7]   Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure [J].
Mancini, DM ;
Katz, SD ;
Lang, CC ;
LaManca, J ;
Hudaihed, A ;
Androne, AS .
CIRCULATION, 2003, 107 (02) :294-299
[8]   A MULTIDISCIPLINARY INTERVENTION TO PREVENT THE READMISSION OF ELDERLY PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
RICH, MW ;
BECKHAM, V ;
WITTENBERG, C ;
LEVEN, CL ;
FREEDLAND, KE ;
CARNEY, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1190-1195
[9]   The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study [J].
Silverberg, DS ;
Wexler, D ;
Sheps, D ;
Blum, M ;
Keren, G ;
Baruch, R ;
Schwartz, D ;
Yachnin, T ;
Steinbruch, S ;
Shapira, I ;
Laniado, S ;
Iaina, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) :1775-1780